OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Luciano D'Adamio

2 Projects | 1 Researchers | $261,054 Invested

2007

RemeGenix, Inc

Luciano D'Adamio, MD, PhD

Commercialization of BR12 peptides for AD

  • Funding Amount: $100,000
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Status: Closed

2006

Albert Einstein College of Medicine

Luciano D'Adamio, MD, PhD

Optimization of GSK-3Beta Inhibitors as multipotent regulators of Tau and APP.

  • Funding Amount: $161,054
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed